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TCF/Lef1-Mediated Control of Lipid Metabolism
Regulates Skin Barrier Function
Dagmar Fehrenschild1,2, Uwe Galli1,2,8, Bernadette Breiden3, Wilhelm Bloch4, Peter Schettina1,2,
Susanne Brodesser5,6, Christian Michels1,6,7, Christian Gu¨nschmann1,6,7, Konrad Sandhoff3,
Carien M. Niessen1,6,7 and Catherin Niemann1,2
Defects in the function of the skin barrier are associated with a wide variety of skin diseases, many of which are
not well characterized at the molecular level. Using Lef1 (lymphoid enhancer-binding factor 1) dominant-
negative mutant mice, we demonstrate here that altered epidermal TCF (T cell factor)/Lef1 signaling results in
severe impairment of the stratum corneum skin barrier and early postnatal death. Barrier defects were
accompanied by major changes in lipid composition and ultrastructural abnormalities in assembly and
extrusion of lipid lamellae of the interfollicular epidermis, as well as abnormal processing of profilaggrin. In
contrast, tight-junction formation and stratified organization of the interfollicular epidermis was not obviously
disturbed in Lef1 mutant mice. Molecular analysis revealed that TCF/Lef1 signaling regulates expression of lipid-
modifying enzymes, such as Elovl3 and stearoyl coenzyme A desaturase 1 (SCD1), which are key regulators of
barrier function. Promoter analysis and chromatin immunoprecipitation experiments indeed showed that SCD1
is a direct target of Lef1. Together, our data demonstrate that functional TCF/Lef1 signaling governs important
aspects of epidermal differentiation and lipid metabolism, thereby regulating skin barrier function.
Journal of Investigative Dermatology (2012) 132, 337–345; doi:10.1038/jid.2011.301; published online 22 September 2011
INTRODUCTION
The skin provides a protective barrier against detrimental
impact of the environment; consequently, multiple skin
diseases are caused by a defective skin barrier function.
During evolution, the skin has developed a number of
structural features that facilitate adequate reactions to
external signals, irritants, and injuries. This barrier is provided
by the stratified epithelium of mammalian epidermis to
prevent water loss to the terrestrial environment and damage
of the organism by pathogenic and harmful agents (Segre,
2006). Keratinocytes of the interfollicular epidermis (IFE)
undergo a sequence of coordinated differentiation steps to form
the protective outermost layer, the stratum corneum. This layer
consists of cornified cells known as corneocytes surrounded by
intercellular lipid lamellae. The program of differentiation is
initiated as cells of the basal layer withdraw from the cell cycle
and detach from the underlying basement membrane to move
upward through suprabasal layers of the IFE. Keratinocytes
rearrange their keratin filaments to provide a durable cyto-
skeletal framework as prerequisite for mechanical strength of
the tissue. Keratin bundles are assembled and proteins,
including involucrin and loricrin, are crosslinked by transglu-
taminase to form an insoluble cornified envelope. Finally, lipid
lamellae delivered to the extracellular environment fill the
space between corneocytes, thereby sealing the tissue for
definite protection of the organism (Nemes and Steinert, 1999).
Work in recent years has begun to understand the basic
elements governing the formation of a functional barrier of
the epidermis (Tsuruta et al., 2002; Segre, 2006). In addition
to a proper execution of the program of terminal differentia-
tion and stratification of keratinocytes, it has been demon-
strated that formation of intercellular tight junctions are
required for acquisition of a protective barrier (Turksen and
Troy, 2002; Kirschner et al., 2010). For instance, mice
deficient in claudin-1, a transmembrane protein of the tight-
junction complex, display marked defects of epidermal
barrier function manifested by an increase in transepidermal
water loss (TEWL) (Furuse et al., 2002).
The stratified epithelium of mammalian skin is derived
from the embryonic ectoderm, and a variety of signals that
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are crucial for development and homeostasis have been
identified previously. Several signaling molecules, including
Delta/Notch, Hedgehog, and BMP family members, are
implicated in regulation of keratinocyte differentiation during
development (Blanpain and Fuchs, 2009). In addition, an
important role emerged for canonical Wnt/b-catenin signal-
ing in controlling a defined differentiation program and
specifying cell fate in mouse epidermis (Niemann, 2006).
The differentiation of hair follicle progenitor cells is
proposed to be driven by b-catenin/Lef1 (lymphoid enhancer-
binding factor 1)-dependent transcription (DasGupta and
Fuchs, 1999; Lowry et al., 2005). Accordingly, hair formation
is blocked, whereas differentiation of stratifying keratinocytes
and sebocytes is stimulated in the epidermis in which b-catenin
signaling is blocked, either through epidermal inactivation of
b-catenin or by transgenic expression of a mutant Lef1 unable
to associate with b-catenin (DNLef1; Huelsken et al., 2001;
Merrill et al., 2001; Niemann et al., 2002).
The impact of an abnormal function of canonical Wnt/
b-catenin or TCF (T cell factor)/Lef1 signaling in skin barrier
function has not been investigated yet. To address this issue, we
set out to investigate the consequences of altering TCF/Lef1
signaling for proper barrier function of mammalian skin by
expressing a mutant DNLef1 in the epidermis.
RESULTS
Defective epidermal barrier function in Lef1 mutant mice
To block functional TCF/Lef1 signaling in mouse epidermis,
we previously generated a transgenic mouse model expres-
sing an N-terminally deleted dominant-negative mutant of
the transcription factor Lef1 under the control of the keratin14
promoter (Niemann et al., 2002). This Lef1 mutant cannot
bind b-catenin, and thus prevents formation of the transcrip-
tional complex required to activate the expression of Wnt/
b-catenin target genes. The mutant Lef1 also inhibits signaling
by other TCF proteins (Niemann et al., 2002).
Genotyping of newborn mice revealed a Mendelian
inheritance ratio of mutant mice (31 wild-type (wt) mice
and 35 mutant mice). In contrast, at weaning age, a reduction
of B50% of mutant mice was observed (29 wt mice and 18
mutant mice; Figure 1a). Mutant mice surviving the first 5
days appeared smaller in size and developed a severe scaling
skin phenotype (Figure 1b). To examine whether impaired
barrier function explains the early postnatal death of mutant
mice, we measured TEWL. Compared with control litter-
mates, Lef1 mutant mice showed a significant increase in the
rate of TEWL (Figure 1c), indicating impaired skin barrier
function. Thus, expression of mutant Lef1 in mouse epidermis
has a profound effect on early postnatal survival likely due to
a strongly reduced skin barrier function.
Next, we wanted to find out whether the epidermal barrier
defect is initiated before birth. Therefore, expression of
mutant Lef1 was analyzed during epidermal morphogenesis.
As expected, mutant Lef1 was strongly expressed from E15.5
onward in basal cells of the IFE, but was also seen in
suprabasal keratinocytes, because of the expansion of keratin
14-positive cell compartment of the IFE. At E18.5, mutant
Lef1 was also detected in the outer root sheath of the hair
follicle (Figure 1d, Supplementary Figure S1a online).
Endogenous Lef1 protein was found in hair bulbs of
developing hair follicles at E18.5 in control skin (Figure 1d).
To analyze whether functional barrier is already disturbed
during late embryonic development, we investigated its
competence to exclude percutaneous dye penetration.
Functional barrier formation starts at the dorsal surface
around E16.5, as demonstrated by toluidine blue dye
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Figure 1. Disrupted epidermal barrier function in Lef1 (lymphoid enhancer-binding factor 1) mutant mice. (a) Postnatal lethality in mutant mice.
Wild-type (wt) and mutant animals expressed as percentage of living mice at birth (wt-b and Mut-b) and at weaning age (wt-w and Mut-w). (b) Image of mice
at 5 days of age displaying reduced body size and scaling of the skin of mutant animals. (c) Transepidermal water loss (TEWL) measured on the back
skin of postnatal mice (n¼4). (d) Immunostaining for Lef1 (green) detects mutant Lef1 protein in the skin of mutant embryos (arrows, right panels).
Endogenous Lef1 production is seen in the bulbs of developing hair follicles at E18.5 (arrowhead). Nuclear counterstaining with propidium iodide is
shown in red. Bar¼80 mm. (e) Toluidine blue dye exclusion assay of wt and Lef1 mutant embryos.
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exclusion, and spreads ventrally, resulting in complete dye
impermeability of the skin around E18.5 in wt mice (Hard-
man et al., 1998). Similar to control mice, Lef1 mutants were
able to exclude dye before birth (Figure 1e), indicating that
the outside-in barrier was formed relatively normal in these
mice. This was confirmed by Lucifer yellow penetration
assays on newborn mice (not shown), which also showed that
Lef1 mutant mice did not exhibit a defective outside-in
barrier at birth that could account for the increased water loss
and subsequent lethality (Figure 1a–c). These data reveal that
despite strong mutant Lef1 expression, the formation of the
epidermal barrier during embryogenesis is not affected.
Instead, the barrier defect becomes evident after birth.
Previous experiments have demonstrated that TCF/Lef1-
dependent reporter gene activity is blocked in primary
keratinocytes isolated from Lef1 mutant mice (Niemann
et al., 2002). We next asked which members of the TCF/
Lef1 transcription factor family are expressed within the IFE of
newborn mice and thus might be responsible for the barrier
defect. Low level of RNA expression of TCF3, TCF4, and Lef1
was detected in IFE using quantitative real time-polymerase
chain reaction (RT-PCR). Therefore TCF3, TCF4, or Lef1
could potentially regulate barrier function. Mutant Lef1
expression did not alter TCF3 or TCF4 expression levels
(Supplementary Figure S1b online).
Tight-junction barrier is not impaired by mutant Lef1
It was previously reported that the outside-in barrier function
was not obviously disturbed in mice with impaired tight
junctions that suffered from water loss (Furuse et al., 2002;
Tungal et al., 2005). We therefore investigated whether tight
junctions were defective in Lef1 mutant mice. First, we
analyzed the expression pattern of tight-junction compo-
nents. Claudin-1 and claudin-4 were normally distributed
and detected at the membrane in 6-day-old and adult wt and
mutant mice (Supplementary Figure S2a online).
To investigate tight-junction formation and function in
primary keratinocytes upon induction of differentiation, a
switch in calcium ion concentration was applied (Mertens
et al., 2005). We detected an increase in claudin-1 and
claudin-4 protein production upon differentiation in primary
keratinocyte cultures of both wt and mutant mice (Supple-
mentary Figure S2b online). Transepithelial resistance mea-
surements showed that keratinocytes of both genotypes were
able to build up comparable epithelial resistance, indicating
that the expression of mutant Lef1 (Supplementary Figure S3
online) does not interfere with the formation of the ionic tight-
junction barrier (Supplementary Figure S2c online). In
addition, mutant keratinocytes were similarly protected
against the penetration of a neutral tracer (Supplementary
Figure S2d online), demonstrating that the tight-junction size
barrier is also properly formed. These results show that the
observed barrier defect in Lef1 mutant epidermis cannot be
explained by impaired function of the tight junctions.
Defective maturation of corneocytes
IFE of newborn and adult Lef1 mutant mice is distinguished
by an increase in the number of epidermal layers and a
thickened stratum corneum (Supplementary Figure S4 on-
line). Ultrastructural analysis of back skin of wt mice revealed
that corneocytes are flat, of regular shape, and densely
packed to form a protective stratum corneum (Figure 2a).
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Figure 2. Maturation of corneocytes and profilaggrin processing are defective in Lef1 (lymphoid enhancer-binding factor 1) mutant skin. (a, b) Morphological
analysis of back skin by transmission electron microscopy of mutant (b) and control littermates (a). SC, stratum corneum; SG, stratum granulosum.
(c) Morphology of corneocytes isolated from wild-type (wt) and Lef1 mutant mice. (d) Surface areas of corneocytes of control (n¼ 703, light gray bars) and
mutant mice (n¼ 884, dark gray bars) were defined using Analysis computer software. (e) Western blot analysis of keratin 10 (K10), involucrin, and profilaggrin
processing in epidermal lysates of 6-day-old wt and Lef1 mutant mice. Bar¼ 700nm (a, b), 100 mm (c).
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In contrast, keratinized cells of stratum corneum of Lef1
mutant skin displayed abnormal shape and size with the
majority of corneocytes being enlarged, thickened, and
distorted (Figure 2b). Many corneosomes were still present
in the initial layers of the stratum corneum maturing from the
stratum granulosum in the epidermis of Lef1 mutant mice
when compared with controls (Figure 2b, arrows). The
surface of the stratum granulosum was even and smooth in
wt skin (Figure 2a), whereas the junction between upper
granular layer and corneocytes was rough and of irregular
shape in mutant skin samples (Figure 2b). Corneocytes were
isolated to assess their size and structure in detail. Close
examination revealed a different form of corneocytes isolated
from mutant mice when compared with wt corneocytes
(Figure 2c). In addition, the average size of corneocytes from
mutant mice was larger (1,683.3mm2) compared with that of
corneocytes from control animals (1,318.6mm2) (Figure 2d).
Next, we investigated whether an altered program of
keratinocyte differentiation could potentially contribute to
defects seen in the IFE. Immunofluorescence analysis of the
hyperproliferative keratin 6 did not detect an increase in
6-day-old Lef1 mutant. Instead, a slight increase in expression
of keratin 10, involucrin, and loricrin was detected in Lef1
mutant mice (Supplementary Figure S4 online). However,
western blot analysis revealed that overall levels of keratin 10
and involucrin were not altered in Lef1 mutant versus control
mice (Figure 2e). Surprisingly, a reduction in distribution of
filaggrin, an important component of cornified envelopes,
was detected by immunofluorescence in the skin of mutant
animals (Supplementary Figure S4 online). During terminal
differentiation of keratinocytes, profilaggrin is processed into
mature filaggrin that is subsequently crosslinked and frag-
mented in mature cells (Scott and Harding, 1986; Smith et al.,
2006). Western blots showed that the monomer band of
filaggrin was strongly reduced in the epidermis of 5-day-old
Lef1 mutant mice compared with wt control tissue. In
addition, filaggrin fragments of 15–25K were also decreased
in Lef1 mutant epidermis (Figure 2e), indicating disturbed
filaggrin production in Lef1 mutant skin. Taken together,
these results indicate that impairment of both differentiation
of keratinocytes and maturation of the stratum corneum are
most likely to contribute to the barrier defect observed in Lef1
mutant mice.
Severe defects in lipid matrix composition
To test whether the lipid barrier is disturbed in the epidermis
of Lef1 mutant mice, freely extractable lipids and those
covalently bound to corneocytes were analyzed from the skin
of mutant and wt mice. First, the content of cholesterol, free
fatty acids, and ceramides of isolated stratum corneum was
determined. The level of total ceramides (cer) was slightly
elevated in Lef1 mutant mice, but levels of cholesterol and
free fatty acids were not significantly altered (Figure 3a).
Quantification of extractable ceramides of stratum corneum
revealed an overall gain in ceramides containing longer fatty
acid (FA) chains in Lef1 mutant mice. Specifically, we
observed an increase in the amount of Cer(EOS) and Cer
(26-AS) and a decrease in Cer(C16-AH/AP) and Cer(AS-16)
(Figure 3c and d). In metabolic studies of epidermis with [14C]
serine, we also found a higher level of Cer(EOS) (data not
shown).
Sphingomyelin is the ceramide precursor for Cer(NS) and
Cer(AS) (Uchida et al., 2000) and glucosylceramide for all
ceramide species, especially ceramides with long- and very
long-chain fatty acids (Hamanaka et al., 2002). Densitometric
quantification of the probarrier lipids showed a decrease
of glucosylceramide and an increase of sphingomyelin
(Figure 3b). Covalently linked lipids are of major importance
for the lipid organization of lamellar structures, and therefore
constitute an essential part of the lipid barrier. Analysis of
covalently bound lipids revealed no alteration in the amount
of o-OH-FA in Lef1 mutant mice (0.71 ngmg–1 dry stratum
corneum (SC) in wt vs. 0.68 ngmg–1 dry SC in mut). However,
a significant reduction in Cer(OS) was seen in mutant skin
(2.27±0.98 ngmg–1 dry SC) compared with control skin
(14.75±1.3 ngmg–1 dry SC; Figure 3e). Therefore, the
increase in Cer(EOS) in mutant Lef1 skin could be caused
by a block of the processing of free Cer(EOS) to protein-
bound ceramide (OS).
Given the strong increase in sebaceous gland (SG)
differentiation in Lef1 mutant mice (Niemann et al., 2002;
Braun et al., 2003), we analyzed the composition of sebum
lipids, such as triglycerides, diglycerides, and esters, in more
detail. Skin samples of mutant mice show a significant
decrease in triglycerides when compared with control
samples (Figure 3f). To a lesser extent, diglyceride fraction
was also reduced, whereas wax esters and cholesterol esters
were not significantly altered within SGs of mutant mice
(Figure 3f). The decline in triglyceride point to a specific
regulation of sebum lipid synthesis by mutant Lef1 and are
not a pure consequence of increase in sebocyte differentia-
tion evident in Lef1 mutant mice. Regulation of lipid barrier is
an early phenotype as similar major changes in the lipid
composition were detected in 5-day-old mutant mice
(Figure 3, Supplementary Figure S5 online). Importantly,
lipid defects are a cell-autonomous consequence of altered
TCF/Lef signaling as no differences in lipid composition were
observed in the liver tissue (Supplementary Figure S6 online).
Impairment of lamellar lipid assembly
To investigate whether aberrant lipid composition affects
assembly of lamellar lipid layers and structure of lamellar
bodies, transmission electron microscopy was performed.
Ultrastructural analysis of Lef1 mutant mouse skin showed
drastic morphological changes of intercellular lipid lamellae.
Mutant keratinocytes in the granular layer contained dis-
organized lipid lamellae and vesicular structures (Figure 4b
and c). These abnormal lipid vesicles were prominent at the
intersection from the upper granular layer to the stratum
corneum and persisted in corneocytes of the lower stratum
corneum (Figure 4b and c and data not shown). In contrast,
lipid lamellae were tightly packed and secretion occurred
normally in the skin of wt mice (Figure 4a). Wild-type lipid
lamellae were equally spaced in both the lamellar body
structures and intercellular spaces of the stratum corneum
(6.4±1.16 nm). In contrast, in Lef1 mutant mice, lamellar
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Figure 3. Abnormal lipid composition in Lef1 (lymphoid enhancer-binding factor 1) mutant mice. (a) Free stratum corneum (SC) lipids of Lef1 mutant mice
and control littermates. Cer, total ceramides; Chol, cholesterol; FA, free fatty acids; wt, wild type. (b) Quantitative analysis of probarrier lipids sphingomyelin
(SM), cholesterol sulfate (CSO4), and glucosyl ceramide (GlcCer). (c, d) Free extractable ceramides from stratum corneum. (c) Representative thin layer
chromatography (TLC) analysis at 5 months and 3 weeks of age. (d) Individual lipid levels of 3-week-old mice quantified by densitometric analysis.
(e) Representative TLC of covalently bound lipids analyzed at 5 months and 3 weeks of age. (f) Decrease in sebum lipids in Lef1 mutant mice demonstrated by
TLC. CE, cholesterol ester; DAG, diglyceride; TAG, triglyceride; WE, wax ester. *Po0.05; **Po0.01; ***Po0.001; ****Po0.0005.
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Figure 4. Defective lamellar bodies in Lef1 (lymphoid enhancer-binding factor 1) mutant mice. (a–c) Transmission electron microscopy reveals abnormal
lamellar body structures within the granular layer of mutant mice (b, c, arrows). Normal lamellar bodies with typical regular lipid lamellae are seen in skin
samples from wild-type mice (a, arrow). SC, stratum corneum; SG, stratum granulosum. Bars¼ 100 nm, inset in a¼ 30nm.
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spacing was consistently increased (8.7±1.19 nm). No lipid
lamellae were seen in lipid vesicles in mutant mice. These
data reveal that specific defects in the lipid content result in
abnormal lipid organization, thereby affecting the selective
barrier in Lef1 mutant mice.
Regulation in lipid-modifying enzymes in Lef1 mutant mice
To unravel the molecular mechanism underlying the lipid
barrier defect induced by aberrant Lef1 signaling, we
screened in an unbiased manner for differentially expressed
genes in mutant mice by subtractive hybridization experi-
ments (data not shown). This revealed that Elovl3 and SCD1
(stearoyl coenzyme A desaturase 1), both important enzymes
of the lipid metabolism, were abnormally expressed in Lef1
mutant mice. Quantitative RT-PCR confirmed that expres-
sions of both Elovl3 and SCD1 were increased in newborn
and adult Lef1 mutant mice (Figure 5a and b and
Supplementary Figure S9a online). Protein levels of SCD1
were also elevated in mutant mice (Figure 5c). Importantly, a
strong reduction in C18:0 saturated fatty acids (and to a lower
extent C16:0), together with an increase in unsaturated fatty
acids (C18:1 and C16:1), in the epidermis from Lef1 mutant
mice when compared with controls indicates an increase in
SCD1 enzyme activity in mutant skin samples (Supplemen-
tary Figure S7 online).
Expression of both enzymes SCD1 and Elovl3 has been
detected within the SG previously. To investigate whether
SCD1 and Elovl3 are also expressed within the IFE,
quantitative RT-PCR analysis was performed on the epider-
mal tissue that had been separated from hair follicle and
underlying dermis. Interestingly, we detect mRNA for both
enzymes within the IFE. However, the level of SCD1 and
Elovl3 expression is not increased in IFE of mutant Lef1
epidermis, suggesting that SCD1 and Elovl3 made by
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Figure 5. SCD1 (stearoyl coenzyme A desaturase 1) is a direct target of mutant Lef1 (lymphoid enhancer-binding factor 1). (a) Increase in ELOVL3 RNA
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keratinocytes of the IFE are most likely not responsible for the
defects of the epidermal lipid barrier in Lef1 mutant mice
(Supplementary Figure S9b online). Next, we performed
immunofluorescence analysis of SCD1 on epidermal whole
mounts of tail skin. As expected, SCD1 protein was detected
in SG of control mice. In contrast, SCD1 protein localized to
SG and ectopic sebocytes along the deformed hair follicle
structures in the skin of Lef1 mutant mice (Supplementary
Figure S8 online).
To investigate whether SCD1 constitutes a potential direct
target of Lef1, the mouse SCD1 upstream promoter sequence
was screened for potential TCF/Lef1-binding sites. Seven
putative TCF/Lef1 consensus-binding sites were identified
within a 2.5-kb region upstream of the ATG translation start
(Figure 5d). Co-transfection of a reporter construct containing
a 2,221-bp upstream region with mutant Lef1 into HaCat or
SW480 cells induced luciferase expression and activity
(Figure 5e), indicating that these sites respond to Lef1
signaling. In contrast, full-length Lef1 cDNA transfection
decreased reporter gene activity significantly.
To identify which of the potential Lef1/TCF consensus sites
are important for the responsiveness, we generated serial
deletion mutants (Figure 5d). Co-transfection of these
fragments together with DNLef1 revealed that the promoter
fragment containing four potential Lef1/TCF sites (Prom2) was
slightly more induced than the shortest SCD1 promoter
fragment harboring only one site (Prom1). The longest
construct spanning all seven binding sites induced the most
potent response. These data suggest that several Lef1/TCF
sites of the SCD1 promoter are involved in the regulation of
SCD1 expression by Lef1 (Figure 5d and e).
To determine whether mutant Lef1 can directly bind to the
endogenous SCD1 promoter, we performed chromatin
immunoprecipitation experiments. An antibody against the
myc tag, which is fused to mutant Lef1, immunoprecipitated
the SCD1 promoter target sequence in keratinocytes isolated
from the mutant but not from the control mice (Figure 5f).
Specific binding of mutant Lef1 protein was seen for TCF/Lef1
consensus-binding sites in Prom2 and Prom3 sequences.
These data reveal that SCD1 is indeed a direct target of
mutant Lef1 in vivo.
DISCUSSION
Our results demonstrate a previously unreported and
important function for TCF/Lef1 DNA-binding proteins in
the formation and maintenance of epidermal barrier. Inter-
ference with TCF/Lef1 signaling in mouse skin induces drastic
changes in the lipid composition and lipid lamellae forma-
tion. As a consequence, a disturbed lipid matrix causes
profound defects in the epidermal lipid barrier. The results
presented here demonstrate that functional TCF/Lef1 signal-
ing governs important aspects of metabolic lipid processing
in mammalian tissues.
In addition to directing crucial aspects of the lipid
metabolism, TCF/Lef1 proteins affect proliferation and
differentiation of keratinocytes of the IFE. In Lef1 mutant
mice, squamous differentiation and formation of corneocytes
was disturbed, and less profilaggrin and filaggrin monomers
were detected. Abnormal differentiation is often seen as a
consequence of a skin barrier defect. However, expansion of
the keratin 14-positive compartment of the IFE was already
evident before the barrier defect at E18 in mutant mice. This
strongly suggests that mutant Lef1 affects differentiation and
maturation of epidermal keratinocytes directly. How mutant
Lef1 modulates the squamous differentiation program of
keratinocytes is at present unclear. Interestingly, Lef1, TCF3,
and TCF4 are expressed within the IFE of newborn mice, and
an important function of TCF3/TCF4 factors for maintenance
of long-term homeostasis of the IFE has been reported
previously (Nguyen et al., 2009). Thus, the results implicate
that Lef1, TCF3, and TCF4 can potentially regulate the barrier
function of mammalian epidermis.
Here we identified SCD1 and Elovl3 as primary targets of
mutant Lef1. Both molecules are key enzymes of mammalian
lipid metabolism and have an important role for skin barrier
function. SCD1, a direct target of mutant Lef1, is a key
enzyme that converts saturated fatty acids into monounsatu-
rated fatty acids. Palmitoyl- and stearoyl-coenzyme A are
preferred substrates used by SCD1 to synthesize palmitoleic
(D9-16:1) and oleic acid (D9-18:1), respectively (Enoch and
Strittmatter, 1978). Global loss of SCD1 and mutations within
the SCD1 locus seen in the asebia mouse model as 2J disrupt
the epidermal lipid barrier and increase TEWL (Sundberg
et al., 2000; Binczek et al., 2007). In addition, lipid matrix
and lipid lamellae are disturbed in SCD1-deficient mice due
to the loss of o-hydroxylated very long-chain fatty acids and
ceramides normally substituted with o-hydroxylated very
long chain fatty acids (Binczek et al., 2007). In contrast, the
fraction of total ceramides, including o-OH ceramides (EOS),
is increased in Lef1 mutant mice and composition of free
extractable ceramides from stratum corneum is altered. Thus,
either lack of SCD1 (SCD1-deficient mice) or increased SCD1
enzyme activity (Lef1 mutant mice) results in disturbances of
the lipid matrix and severe skin barrier defects.
Mutant Lef1 also upregulates transcription of Elovl3, a
member of a highly conserved family of microsomal enzymes
(Tvrdik et al., 2000) that mediate formation of very long-chain
fatty acids. This is especially interesting in the light of our
findings that mutant Lef1 is increasing the level of ceramides
containing longer FA, which is associated with a decrease in
ceramides with shorter FA. It has been shown previously that
targeted mutation of the elovl3 gene results in severe defects
of the epidermal barrier and abnormal lipid composition
(Westerberg et al., 2004).
The characterization of the barrier defect of Lef1 mutant
mice complements a list of mouse mutants carrying defects in
the skin barrier function that are accompanied by abnormal
sebaceous lipid composition and changes in sebaceous gland
physiology (see, e.g., Binczek et al., 2007). However, the
exact mechanism of how disturbed sebaceous gland func-
tions contribute to the defective lipid and skin barrier is not
understood yet.
Covalently linked lipids are unique to the epidermis
(Werzt and Downing, 1987) and are key components of the
extracellular lamellae and corneocyte lipid envelope, which
is the covalently attached bilayer of the cornified envelope
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(Marekov and Steinert, 1998; Bouwstra et al., 2003). We
demonstrate a significant decrease in the Cer(OS) protein-
bound fraction of ceramides in skin of Lef1 mutant mice. This
is due to a block in processing of free ceramides (e.g.,
Cer(EOS)), a lipid fraction that was accumulating in mutant
skin. As a result, the lamellar lipid matrix and consequently
lamellar bodies in stratum granulosum are highly disturbed.
This became evident by lipid lamellae that are not well
organized and often displaced by vesicular lipid aggregates.
Furthermore, our results suggest that variations in ceramide
and lipid composition can profoundly affect the spacing of
lamellar structures (Figure 5g).
Many human sebaceous tumors harbor mutations within
the Lef1 gene. These mutations lie within the b-catenin-
binding domain and abolish interaction of Lef1 with
b-catenin, resulting in a block of transcriptional activation
(Takeda et al., 2006). Lef1 mutant mice also develop
spontaneous sebaceous tumors (Niemann et al., 2002). Until
now, it is not known whether a defective epidermal barrier
could also be contributing to the formation of skin cancer.
Furthermore, abnormal constitution of the lipid matrix could
profoundly affect tumor growth. In the future, it will be
exciting to explore whether mutations within the components
of TCF/Lef1 signaling are also underlying pathological defects
in human barrier diseases.
MATERIALS AND METHODS
Mice
Lef1 mutant mice (K14DNLef1) have been described previously
(Niemann et al., 2002) and have been backcrossed into a pure
C57Bl/6 background. Postnatal lethality was monitored from a total
of 10 litters. Experiments were performed according to institutional
guidelines and animal license given by the State Office North Rhine-
Westphalia, Germany.
Epidermal protein extraction and western blot analysis
Protein extracts were isolated from skin samples and processed for
western blot analysis following standard protocols (Supplementary
Information online).
Isolation of corneocytes
Mouse ear tips were incubated with 25mM dithiothreitol and 2%
SDS for 15minutes at 100 1C and centrifuged afterward. Corneocytes
were resuspended in 10mM Tris, 1mM EDTA buffer (pH 8.0) and
images of cornified envelopes were taken using an Olympus CK 40
microscope and analyzed with an Analysis computer program
(Tokyo, Japan).
Ultrastructural analysis
Back skin from wt and K14DNLef1 mutant mice was fixed in 2%
formaldehyde, 2% glutaraldehyde in 100mM cacodylate buffer (pH
7.4) and postfixed with either 0.2% ruthenium tetroxide or 1%
osmium tetroxide. Samples were dehydrated and then embedded in
Araldite (Serva, Heidelberg, Germany). Semithin (500 nm) and
ultrathin sections (30–60 nm) for light and electron microscopic
observation were processed on an ultramicrotome (Fa. Reichert,
Vienna, Austria). Semithin sections were stained using methylene
blue. Transmission electron microscopy was performed using a
902A electron microscope from Zeiss (Oberkochen, Germany).
Quantitative RT-PCR
Quantitative RT-PCR experiments were conducted according to
standard methods (Supplementary Information online).
Chromatin immunoprecipitation
Chromatin immunoprecipitation assays and reporter assays were
performed as described in Supplementary Information online.
Lipid analysis
Stratum corneum preparation and lipid analyses were performed as
described previously (Reichelt et al., 2004, Supplementary Informa-
tion online).
Functional tests of the epidermal barrier
The rate of TEWL was determined with a Tewameter (Courage and
Khazaka Electronic GmbH, Cologne, Germany) as described by
Clarys and Barel (1995). Dye exclusion assays were performed as
described before (Hardman et al., 1998).
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